cas 445003-37-2|| where to buy tert-Butyl 4-bromo-2-methylbenzoate

製品名:tert-Butyl 4-bromo-2-methylbenzoate

IUPAC Name:tert-butyl 4-bromo-2-methylbenzoate

包装単位	有効在庫	価格（USD）
CM154849-250mg	in stock	ȌƱ
CM154849-1g	in stock	ƱȷȦ
CM154849-5g	1-2 Weeks	ȷƋǲ
CM154849-25g	1-2 Weeks	ƱȷǲǕ

研究開発用専用.

問い合わせフォーム

化学物質名

CAS番号

数量*

要求仕様*
（アッセイ %、材料グレード等）

お名前*

連絡先Eメールアドレス*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 445003-37-2 regularly via the above email.

追記事項

Verification code*

refresh

: CAS番号:445003-37-2; 分子式:C12H15BrO2; 融点:-; SMILESコード:O=C(OC(C)(C)C)C1=CC=C(Br)C=C1C; 密度:

: カタログ番号:CM154849; 分子量:271.15; 沸点:; MDL番号:MFCD08703427; 保管方法:

: Benzenes; Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

: Encaleret; New England Journal of Medicine(NEJM) publication of positive encaleret proof-of-concept phase 2b results in patients with autosomal dominant hypocalcemia type 1 (ADH1).
Encaleret is an investigational, orally administered small molecule that selectively antagonizes the calcium sensing receptor (CaSR), targeting ADH1 at its source. If approved, encaleret could be the first therapy specifically indicated for the treatment of ADH1.
Encaleret has received fast track designation by the U.S. FDA and orphan drug designation in the United States and the European Union.